Priorité prévention : Rester en bonne santé tout au long de sa vie. Feuille de route stratégie nationale de santé sexuelle 2018-2020
La stratégie nationale de santé constitue le cadre de la politique de santé en France.
La stratégie nationale de santé constitue le cadre de la politique de santé en France.
Given the vulnerability of key populations, this strategy seeks to operationalise current global, continental and regional commitments and address these gaps by providing Member States with a framework to develop specific programming aimed at key populations.
La situation épidémique de certaines infections sexuellement transmissibles (IST) en Guyane et aux Antilles françaises est préoccupante.
El Plan Nacional sabre Drogas, Legitimación de Capitales y Financiamiento al Terrorismo (PND), es un instrumento que permite ordenar la acción estatal y maximizar el usa de los recursos, definiendo una serie de intervenciones en cuatro ejes estratégicos, siendo uno de ellos el de prevenir que la
The development of the LGBTI+ National Youth Strategy (the Strategy) is a key commitment for the Department of Children and Youth Affairs (DCYA) as part of the 2016 Programme for Partnership Government.
We conducted a systematic review to assess the impact of school-based condom availability programs (CAPs) on condom acquisition, use and sexual behavior. We searched PubMed to identify English-language studies evaluating school-based CAPs that reported process (i.e.
The international evidence is clear.
This Strategic Plan is organized into six sections. The Introduction to the Plan provides brief historical background information on the Ministry of Gender, Children and Social Protection's Department of Gender which is followed by the rationale for developing the Plan.
The situational analysis attempts to determine how the intersection of youth and disability contributes to the challenge of accessing SRHR.
Presenta el plan que tiene como objetivo incrementar el número de adolescentes de 15 a 19 años protegidas eficaz y apropiadamente por la anticoncepción, pasando de 61.200 a 162.500.